Cf. Van Der Walle et al., Solution-structure of a peptide designed to mimic the C-terminal hexapeptide of endothelin, J PHARM PHA, 50(8), 1998, pp. 837-844
The peptide: Ac-cyclo(Cys-His-Leu-Asp-Cys)-Ile-Trp-OH, has been designed by
computer-aided molecular-modelling techniques to mimic the proposed a-heli
cal conformation of the C-terminal hexapeptide of endothelin,
Two-dimensional proton nuclear magnetic resonance spectra were acquired for
the peptide dissolved in d(6)-DMSO or D2O-H2O and the distance and angle c
onstraints incorporated into simulated annealing experiments. Conformers ge
nerated from the D2O-H2O data superposed on the corresponding main-chain at
oms in the crystal structure of endothelin 1 and the solution structure of
BQ-123 with root mean square co-ordinate differences of 0.9 Angstrom and 0.
77 Angstrom, respectively. The peptide did not elicit antagonism of endothe
lin-induced in-vitro contractions of rabbit aorta (endothelin A receptor) o
r rabbit bronchus (endothelin B receptor) preparations.
Because the peptide can adopt a conformer which closely matches the equival
ent residues in the endothelin 1 crystal structure and in BQ-123, we sugges
t BQ-123 does not necessarily mimic the endothelin C-terminal region to ach
ieve its antagonism, and that a helical conformation of the endothelin C-te
rminal hexapeptide does not favour its interaction at the endothelin B rece
ptor.